David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
BHP
BHP
$246B
| $28.8M | 0.04% |
732,194
+319,851
| +78% | +$13M |
|
|
SIAL
477
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $28.6M | 0.04% |
207,157
-233,092
| -53% | -$32.1M |
|
478
ICICI Bank
IBN
$107B
| $28.6M | 0.04% |
+3,032,218
| New | +$31.5M |
|
|
WFT
479
DELISTED
Weatherford International plc
WFT
| $28.5M | 0.04% |
2,316,361
-1,494,272
| -39% | -$17.4M |
|
480
Microchip Technology
MCHP
$41.3B
| $28.3M | 0.04% |
1,159,236
+66,498
| +6% | +$1.6M |
|
481
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $28.3M | 0.04% |
196,000
-411,300
| -68% | -$60.5M |
|
482
Arch Capital
ACGL
$33.9B
| $28.3M | 0.04% |
1,376,103
+444,426
| +48% | +$8.9M |
|
483
CALL
3M
MMM
$92.3B
| $28.1M | 0.04% |
203,798
+43,773
| +27% | +$6.03M |
|
|
WBMD
484
DELISTED
WebMD Health Corp.
WBMD
| $28.1M | 0.04% |
640,011
+29,515
| +5% | +$1.23M |
|
485
Prologis
PLD
$135B
| $28M | 0.04% |
642,987
-2,356,946
| -79% | -$103M |
|
486
CALL
Lockheed Martin
LMT
$130B
| $28M | 0.04% |
137,900
-10,000
| -7% | -$1.97M |
|
487
Devon Energy
DVN
$54B
| $28M | 0.04% |
463,507
-838,133
| -64% | -$51.1M |
|
|
FOLD
488
DELISTED
Amicus Therapeutics
FOLD
| $28M | 0.04% |
2,569,326
-486,838
| -16% | -$4.29M |
|
489
Alnylam Pharmaceuticals
ALNY
$31.6B
| $27.9M | 0.04% |
267,612
+76,353
| +40% | +$7.74M |
|
490
Graham Holdings Company
GHC
$4.94B
| $27.9M | 0.04% |
44,016
-5,948
| -12% | -$3.51M |
|
|
B
491
PUT
Barrick Mining
B
$78.3B
| $27.9M | 0.04% |
2,545,900
-4,635,200
| -65% | -$54.8M |
|
492
Rio Tinto
RIO
$171B
| $27.8M | 0.04% |
670,943
+661,095
| +6,713% | +$29.9M |
|
493
O'Reilly Automotive
ORLY
$72.1B
| $27.7M | 0.04% |
1,921,080
-719,205
| -27% | -$9.66M |
|
|
VAL
494
DELISTED
Valspar
VAL
| $27.5M | 0.04% |
327,420
-189,049
| -37% | -$16.3M |
|
|
ENLC
495
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $27.4M | 0.04% |
842,885
+52,279
| +7% | +$1.73M |
|
496
PUT
Ford
F
$57.5B
| $27.3M | 0.04% |
1,688,500
-3,532,100
| -68% | -$55.7M |
|
497
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $27.2M | 0.04% |
484,000
+245,000
| +103% | +$13.7M |
|
498
HCA Healthcare
HCA
$92.9B
| $27.1M | 0.04% |
359,928
-1,708,167
| -83% | -$123M |
|
|
SWI
499
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $27M | 0.04% |
527,352
+62,589
| +13% | +$3.11M |
|
500
TripAdvisor
TRIP
$1.17B
| $27M | 0.04% |
324,850
-269,616
| -45% | -$21.2M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.